Business
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2026
Dallas, Texas--(Newsfile Corp. - February 18, 2026) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). Incannex continued to build the clinical and patient-reported evidence base for IHL-42X in obstructive sleep apnea (OSA), following full Phase 2 RePOSA data and exit-interview analyses. Both low and high-dose IHL-42X achieved statistically significant reductions in Apnea-Hypopnoea Index (AHI) versus...
About this update from Incannex Healthcare Inc.
[{"type":"text","content":"Dallas, Texas--(Newsfile Corp. - February 18, 2026) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). Incannex continued to build the clinical and patient-reported evidence base for IHL-42X in obstructive sleep apnea (OSA), following full Phase 2 RePOSA data and exit-interview analyses. Both low and high-dose IHL-42X achieved statistically significant reductions in Apnea-Hypopnoea Index (AHI) versus placebo, with maximum AHI reductions of up to 83% in the high-dose arm. Exit interviews showed 57.6% of participants reported perceived improvement in their OSA, and most of those described the change as meaningful to daily life. IHL-42X was well tolerated across both dose cohorts, reinforcing its potential for broad use.","length":813,"tagName":"p"},{"type":"text","content":"To view the full announcement, including downloadable images, bios, and more, click here.","length":89,"tagName":"p"},{"type":"text","content":"Key Takeaways:","length":14,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"IHL-42X receives fast track approval","length":36,"tagName":"p"}]},{"val":[{"type":"text","content":"$68.9M in reported cash & cash equivalents","length":46,"tagName":"p"}]},{"val":[{"type":"text","content":"Positive Phase 2 results for PSX-001","length":36,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":118,"olType":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":550,"height":147,"url":"https://media.zenfs.com/en/newsfile_64/1c10f493ba8ab094a74150eb977c7828"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/SVMgVgxqdmi3xxbFRcWEnQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI1NztjZj13ZWJw/https://media.zenfs.com/en/newsfile_64/1c10f493ba8ab094a74150eb977c7828","width":550,"height":147}},"href":"https://api.newsfilecorp.com/redirect/87DJDiO4L8","hrefExternal":true},{"type":"text","content":"Click image above to view full announcement.","length":44,"tagName":"p","attribs":{}},{"type":"horizontalRule"},{"type":"text","content":"About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our...